Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Two Elan neurology products move closer to market in U.S.

Jan. 12, 1999

Preparation and use of new class of tachykinin antagonists disclosed by MS&D

Jan. 12, 1999

Abbott files for marketing approval of novel ICU sedative and analgesic compound

Jan. 11, 1999

Sibia Neurosciences completes phase I study of SIB-1553A and initiates phase II study

Jan. 11, 1999

Pharmacokinetic profile of edaravone, a novel antioxidant from Mitsubishi Chemical

Jan. 8, 1999

Creative BioMolecules licenses neurotrophic protein from Cambridge NeuroScience

Jan. 8, 1999

Histamine H3 antagonist ciproxifan shows positive behavioral effects in animal models

Jan. 8, 1999

Mexiletine effectively controls spasmodic torticollis in treatment-refractory patients

Jan. 8, 1999

Diatide receives patent protection for novel cancer pain treatment

Jan. 8, 1999

Remacemide provides neuroprotection during CPB

Jan. 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...